Polmacoxib/Pregabalin

N/A

Report date: 2025/07/30 14:53:59

Base Information

Drug NamePolmacoxib/Pregabalin
Drug Alias NameCG-651
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-2 inhibitorsVoltage-gated calcium channel alpha2/delta subunit 1 blockers
TargetsCyclooxygenase-2Voltage-gated calcium channel alpha2/delta subunit 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes PolmacoxibPregabalin
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrystalgenomics Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A